Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/03/063657
CTRI/2024/03/063657
Not yet recruiting
Phase 2

To evaluate the safety and efficacy of the test products in comparison to baseline in improving hair growth rate and reducing hair fall among healthy subjects - NI

Marico Limited0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Marico Limited
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\.Male and female subjects in general good health.
  • •2\.Subjects in the age group 18\-50 years (both the ages inclusive).
  • •3\.Subjects complaining of hair fall and damage.
  • •4\.Subjects willing to give a written informed consent and willing to abide by and comply with the study protocol.
  • •5\.Hair density of greater than 100 and less than 200 hair follicle per square cm as per TrichoScan measurement
  • •6\.Male and female Subjects falling under Grade 3 \- Grade 6 of hair loss severity grade evaluated as per MSCR photo numerical 10\-point scale (Linear scale for assessment purpose\-In Use Scale).

Exclusion Criteria

  • •1 Subjects who have undergone any kind of hair growth treatment in the last 3 months
  • •2 Subjects having any active but controllable scalp disease which may interfere in the study assessments
  • •3 Subjects who have taken chemotherapy for cancer in the 6 months prior to the studys start
  • •4 Subjects who have history of crash dieting and or psychiatric disorder including trichotillomania
  • •5 Subjects who have undergone hair transplant
  • •6 A known history or present condition of allergic response or hypersensitivity to any topical or oral cosmetic pharmaceutical or nutraceutical product
  • •7 Subjects on oral medications like topical or systemic corticosteroids undergoing any chemical hair salon treatment which will compromise the study
  • •8 Subjects with chronic illness which may influence the cutaneous state
  • •9 Subjects who are pregnant or nursing Self declared
  • •10 Subjects with any history or present of underlying uncontrolled medical illness or any other serious medical illness

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Evaluation test about safety and efficacy of the respiratory muscle training therapy by abdominal respiratory weight exercises in chronic cardiovascular disease patientsChronic cardiovascular disease
JPRN-UMIN000021661Kurume University School of Medicine90
Completed
Not Applicable
A study to evaluate the safety of the test product in healthy female subjects of normal eye condition, sensitive eye condition and contact lens users.
CTRI/2015/11/006334ITC Life Science and Technology Centre40
Completed
Not Applicable
Examination of the Effects and Safety of a Test Food Ingestion on Knee Pain and Motility Function: A Placebo-Controlled, Randomized, Double-Blind, Parallel-Group Study/A(healthy adults)
JPRN-UMIN000035251TES Holding Co., Ltd.70
Active, not recruiting
Not Applicable
Ensayo para evaluar la eficacia, seguridad y tolerabilidad, de una estrategia de simplificacion temprana a Trizivir, en pacientes con supresion virologica tras tratamiento antiretroviral con Combivir mas Lopinavir/Ritonavir (Kaletra).HIV INFECTIO
EUCTR2004-002296-16-ESAntonio Antela López142
Completed
Phase 2
A study to see if the product makes your skin appear younger
CTRI/2024/03/064059Ichimaru Pharcos Co Ltd38